APA (7th ed.) Citation

Horisaki, K., Yoshikawa, S., Omata, W., Tsutsumida, A., & Kiyohara, Y. (2025). Comparison of the efficacy of rechallenge with anti-PD-1 antibody monotherapy and BRAF/MEK inhibitor in advanced malignant melanoma. Dermatologica Sinica, 43(2), 134-137. https://doi.org/10.4103/ds.DS-D-25-00005

Chicago Style (17th ed.) Citation

Horisaki, Ken, Shusuke Yoshikawa, Wataru Omata, Arata Tsutsumida, and Yoshio Kiyohara. "Comparison of the Efficacy of Rechallenge with Anti-PD-1 Antibody Monotherapy and BRAF/MEK Inhibitor in Advanced Malignant Melanoma." Dermatologica Sinica 43, no. 2 (2025): 134-137. https://doi.org/10.4103/ds.DS-D-25-00005.

MLA (9th ed.) Citation

Horisaki, Ken, et al. "Comparison of the Efficacy of Rechallenge with Anti-PD-1 Antibody Monotherapy and BRAF/MEK Inhibitor in Advanced Malignant Melanoma." Dermatologica Sinica, vol. 43, no. 2, 2025, pp. 134-137, https://doi.org/10.4103/ds.DS-D-25-00005.